Association of glutathione S-transferase Ω 1-1 polymorphisms (A140D and E208K) with the expression of interleukin-8 (IL-8), transforming growth factor beta (TGF-β), and apoptotic protease-activating factor 1 (Apaf-1) in humans chronically exposed to arsenic in drinking water

Archives of Toxicology

Volumn 86, Issue 6, 2012, Pages 857-868

  Escobar Garcia D M ^a   Del Razo, L M ^b   Sanchez Pena L C ^b   Mandeville, P B ^a   Lopez Campos, C ^c   Escudero Lourdes, Claudia ^a  

^a UNIVERSIDAD AUTÓNOMA DE SAN LUIS POTOSÍ   (Mexico)

^b DEPARTAMENTO DE FÍSICA   (Mexico)

^c Facultad de Medicina de la Universidad de Coahuila   (Mexico)

Author keywords

A140D; Apoptosis; Arsenic; E208K; GSTO1 1; InXammation; Polymorphisms

Indexed keywords

ALANINE; APOPTOTIC PROTEASE ACTIVATING FACTOR 1; ARSENIC; ASPARTIC ACID; DRINKING WATER; GLUTAMIC ACID; INTERLEUKIN 8; LYSINE; TRANSFORMING GROWTH FACTOR BETA;

ADOLESCENT; ADULT; APOPTOSIS; APOPTOTIC PROTEASE ACTIVATING FACTOR 1 GENE; ARTICLE; CHILD; CLINICAL EVALUATION; CONTROLLED STUDY; FEMALE; GENE; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENE LOCATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC CODE; GENETIC RISK; GLUTATHIONE TRANSFERASE OMEGA 1 1 GENE; HAPLOTYPE; HETEROZYGOSITY; HUMAN; INTERLEUKIN 8 GENE; LONG TERM EXPOSURE; MALE; POPULATION RISK; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSFORMING GROWTH FACTOR BETA GENE; WATER ANALYSIS;

ADOLESCENT; ADULT; APOPTOSIS; APOPTOTIC PROTEASE-ACTIVATING FACTOR 1; ARSENIC; ARSENIC POISONING; CHILD; CHILD, PRESCHOOL; DRINKING WATER; ENVIRONMENTAL EXPOSURE; FEMALE; FOOD CONTAMINATION; GLUTATHIONE TRANSFERASE; HUMANS; INFLAMMATION; INTERLEUKIN-8; MALE; MEXICO; MIDDLE AGED; POLYMORPHISM, GENETIC; TRANSFORMING GROWTH FACTOR BETA; YOUNG ADULT;

EID: 84866031788     PISSN: 03405761     EISSN: 14320738     Source Type: Journal    
DOI: 10.1007/s00204-012-0802-x     Document Type: Article

References (66)

1. Aguirre-Bañuelos P, Escudero-Lourdes C, Sanchez-Peña LC, Del Razo LM, Perez-Urizar J (2008) Inorganic arsenic exposure aVects pain behavior and inXammatory response in rat. Toxicol Appl Pharmacol 229:374-385
2. Agusa T, Kunito T, Kubota R, Inoue S, Fujihara J, Minh TB, Ha NN, Tu NP, Trang PT, Chamnan C, Takeshita H, Iwata H, Tuyen BC, Viet PH, Tana TS, Tanabe S (2010) Exposure, metabolism, and health eVects of arsenic in residents from arsenic-contaminated groundwater areas of Vietnam and Cambodia: a review. Rev Environ Health 25:193-220
3. Apostolakis S, Vogiatzi K, Amanatidou V, Spandidos DA (2009) Interleukin 8 and cardiovascular disease. Cardiovasc Res 84:353-360
4. Balkwill F (2003) Chemokine biology in cancer. Review. Semin Immunol 15:49-55
5. Balkwill F, Mantovani A (2001) InXammation and cancer: back to Virchow? Review. Lancet 357:539-545
6. Beard NA, Wei L, Dulhunty AF (2009) Control of muscle ryanodine receptor calcium release channels by proteins in the sarcoplasmic reticulum lumen. Clin Exp Pharmacol Physiol 36:340-345
7. Berglund M, Lindberg AL, Rahman M, Yunus M, Grandér M, Lönnerdal B, Vahter M (2011) Gender and age diVerences in mixed metal exposure and urinary excretion. Environ Res 111(8):1271-1279
8. Black PC, Dinney CP (2007) Bladder cancer angiogenesis and metastasis-translation from murine model to clinical trial. Cancer Metastasis Rev 26:623-634
9. Blobe GC, Schiemann WP, Lodish HF (2000) Role of transforming growth factor beta in human disease. N Engl J Med 342:1350-1358
10. Board PG, Coggan M, Cappello J, Zhou H, Oakley AJ, Anders MW (2008) S-(4-Nitrophenacyl) glutathione is a speciWc substrate for glutathione transferase omega 1-1. Anal Biochem 374:25-30
11. Bretz F, Hothorn T, Westfall PH (2011) Multiple comparisons using R. CRC Press, Boca Raton
12. Bunderson M, Brooks DM, Walker DL, Rosenfeld ME, CoYn JD, Beall HD (2004) Arsenic exposure exacerbates atherosclerotic plaque formation and increases nitrotyrosine and leukotriene biosynthesis. Toxicol Appl Pharmacol 201:32-39
13. Cáceres DD, Werlinger F, Orellana M, Jara M, Rocha R, Alvarado SA, Luis Q (2010) Polymorphism of glutathione S-transferase (GST) variants and its eVect on distribution of urinary arsenic species in people exposed to low inorganic arsenic in tap water: an exploratory study. Arch Environ Occup Health 65:140-147
14. Cain K (2003) Chemical-induced apoptosis: formation of the Apaf-1 apoptosome. Drug Metab Rev 35:337-363
15. Caroppi P, Sinibaldi F, Fiorucci L, Santucci R (2009) Apoptosis and human diseases: mitochondrion damage and lethal role of released cytochrome C as proapoptotic protein. Curr Med Chem 16:4058-4065
16. Chen YC, Guo YL, Su HJ, Hsueh YM, Smith TJ, Ryan LM (2003a) Arsenic methylation and skin cancer risk in south-western Taiwan. J Occup Environ Med 45:241-248
17. Chen YC, Su HJ, Guo YL, Hsueh YM, Smith TJ, Ryan LM (2003b) Arsenic methylation and bladder cancer risk in Taiwan. Cancer Causes Control 14:303-310
18. Chikazawa M, Inoue K, Fukata S, Karashima T, Shuin T (2008) Expression of angiogenesis-related genes regulates diVerent steps in the process of tumor growth and metastasis in human urothelial cell carcinoma of the urinary bladder. Pathobiology 75:335-345
19. Dani SU (2010) Arsenic for the fool: an exponential connection. Sci Total Environ 408:1842-1846
20. De Vizcaya-Ruiz A, Barbier O, Ruiz-Ramos R, Cebrian ME (2009) Biomarkers of oxidative stress and damage in human populations exposed to arsenic. Mutat Res 674:85-92
21. Del Razo LM, Arellano MA, Cebrián ME (1990) The oxidation states of arsenic in well-water from a chronic arsenicism area of northern Mexico. Environ Pollut 64:143-153
22. Del Razo LM, Styblo M, Cullen WR, Thomas DJ (2001) Determination of trivalent methylated arsenicals in biological matrices. Toxicol Appl Pharmacol 174:282-293
23. Drobná Z, Walton FS, Paul DS, Xing W, Thomas DJ, Stýblo M (2010) Metabolism of arsenic in human liver: the role of membrane transporters. Arch Toxicol 84:3-16
24. Dulhunty A, Gage P, Curtis S, Chelvanayagam G, Board P (2001) The glutathione transferase structural family includes a nuclear chloride channel and a ryanodine receptor calcium release channel modulator. J Biol Chem 276:3319-3323
25. Engel RR, Hopenhayn-Rich C, Receveur O, Smith AH (1994) Vascular eVects of chronic arsenic exposure: a review. Epidemiol Rev 16:184-209
26. Escudero-Lourdes C, Medeiros MK, Cárdenas-González MC, Wnek SM, GandolW JA (2010) Low level exposure to monomethyl arsonous acid-induced the over-production of inXammation-related cytokines and the activation of cell signals associated with tumor progression in a urothelial cell model. Toxicol Appl Pharmacol 244:162-173
27. Guha Mazumder DN (2008) Chronic arsenic toxicity & human health. Indian J Med Res 128:436-447
28. Gustafson B (2010) Adipose tissue, inXammation and atherosclerosis. J Atheroscler Thromb 17(4):332-341
29. Huang C, Ke Q, Costa M, Shi X (2004) Molecular mechanisms of arsenic carcinogenesis. Mol Cell Biochem 255:57-66
30. Jiang X, McDermott JR, Ajees AA, Rosen BP, Liu Z (2010) Trivalent arsenicals and glucose use diVerent translocation pathways in mammalian GLUT1. Metallomics 2:211-219
31. Kalman DA, Hughes J, van Belle G, Burbacher T, Bolgiano D, Coble K, Mottet NK, Polissar L (1990) The eVect of variable environmental arsenic contamination on urinary concentrations of arsenic species. Environ Health Perspect 89:145-151
32. Karagas MR, Tosteson TD, Morris JS, Demidenko E, Mott LA, Heaney J (2004) Incidence of transitional cell carcinoma of the bladder and arsenic exposure in New Hampshire. Cancer Causes Control 15:465-472
33. Kile ML, HoVman E, Hsueh YM, Afroz S, Quamruzzaman Q, Rahman M, Mahiuddin G, Ryan L, Christiani DC (2009) Variability in biomarkers of arsenic exposure and metabolism in adults over time. Environ Health Perspect 117:455-460
34. Kumagai Y, Sumi D (2007) Arsenic: signal transduction, transcription factor, and biotransformation involved in cellular response and toxicity. Annu Rev Pharmacol Toxicol 47:243-462
35. Kurttio P, Komulainen H, Hakala E, Kahelin H, Pekkanen J (1998) Urinary excretion of arsenic species after exposure to arsenic present in drinking water. Arch Environ Contam Toxicol 34(3):297-305
36. Laliberte RE, Perregaux DG, Hoth LR, Rosner PJ, Jordan CK, Peese KM, Eggler JF, Dombroski MA, Geoghegan KF, Gabel CA (2005) Glutathione s transferase omega 1-1 is a target of cytokine release inhibitory drug and may be responsible for their eVect on interleukin 1 posttranslational processing. J Biol Chem 278:16567-16578
37. Lantz RC, Hays AM (2006) Role of oxidative stress in arsenic-induced toxicity. Drug Metab Rev 38:791-804
38. Lemarie A, Morzadec C, Bourdonnay E, Fardel O, Vernhet L (2006) Human macrophages constitute targets for immunotoxic inorganic arsenic. J Immunol 177:3019-3027
39. Li YJ, Scott WK, Zhang L, Lin PI, Oliveira SA, Skelly T, Doraiswamy MP, Welsh-Bohmer KA, Martin ER, Haines JL, Pericak-Vance MA, Vance JM (2006) Revealing the role of glutathione S-transferase omega in age-at-onset of Alzheimer and Parkinson diseases. Neurobiol Aging 27:1087-1093
40. Marahatta SB, Punyarit P, Bhudisawasdi V, Paupairoj A, Wongkham S, Petmitr S (2006) Polymorphism of glutathione-S-transferase omega gene and risk of cancer. Cancer Lett 236:276-281
41. Marnell LL, Garcia-Vargas GG, Chowdhury UK, Zakharyan RA, Walsh B, Avram MD, Kopplin MJ, Cebrian ME, Silbergeld EK, Aposhian HV (2003) Polymorphisms in the human Monomethyl arsonic Acid (MMAV) reductase/hGSTO1 gene and changes in urinary arsenic proWles. Chem Res Toxicol 16:1507-1513
42. Meliker JR, Wahl RL, Cameron LL, Nriagu JO (2007) Arsenic in drinking water and cerebrovascular disease, diabetes mellitus, and kidney disease in Michigan: a standardized mortality ratio analysis. Environ Health 6(4):1-11
43. Méndez-Gómez J, García-Vargas GG, López-Carrillo L, Calderón-Aranda ES, Gómez A, Vera E, Valverde M, Cebrián ME, Rojas E (2008) Genotoxic eVects of environmental exposure to arsenic and lead on children in region Lagunera, Mexico. Ann N Y Acad Sci 1140:358-367
44. Mukherjee B, Salavaggione OE, Pelleymounter LL, Moon I, EckloV BW, Schaid DJ, Wieben ED, Weinshilboum RM (2006) Glutathione S-transferase omega 1 and omega 2 pharmacogenomics. Drug Metab Dispos 7:1237-1246
45. Piaggi S, Raggi C, Corti A, Pitzalis E, Mascherpa MC, Saviozzi M, Pompella A, Casini AF (2010) Glutathione transferase omega 1-1 (GSTO1-1) plays an anti-apoptotic role in cell resistance to cisplatin toxicity. Carcinogenesis 31(5):804-811
46. Pongstaporn W, Pakakasama S, Sanguansin S, Hongeng S, Petmitr S (2009) Polymorphism of glutathione S-Transferase Omega gene: association with risk of childhood acute lymphoblastic leukemia. J Cancer Res Clin Oncol 135:673-678
47. Rahman MM, Ng JC, Naidu R (2009) Chronic exposure of arsenic via drinking water and its adverse health impacts on humans. Environ Geochem Health Suppl 1:189-200
48. Sampayo-Reyes A, Hernández A, El-Yamani N, López-Campos C, Mayet-Machado E, Rincón-Castañeda CB, Limones-Aguilar Mde L, López-Campos JE, de León MB, González-Hernández S, Hinojosa-Garza D, Marcos R (2010) Arsenic induces DNA damage in environmentally exposed Mexican children and adults. InXuence of GSTO1 and AS3MT polymorphisms. Toxicol Sci 117(1):63-71
49. Schläwicke Engström K, Broberg K, Concha G, Nermell B, Warholm M, Vahter M (2007) Genetic polymorphisms inXuencing arsenic metabolism: evidence from Argentina. Environ Health Perspect 115(4):599-605
50. Shi H, Xianglin S, Ke J (2004) Oxidative mechanism of arsenic toxicity and carcinogenesis. Mol Cell Biochem 255:67-78
51. Siegel PM, Massague J (2003) Cytostatic and apoptotic actions of TGF-eta in homeostasis and cancer. Nat Rev Cancer 3:807-821
52. Simeonova PP, Hulderman T, Harki D, Luster MI (2003) Arsenic exposure accelerates atherogenesis in apolipoprotein E mice. Environ Health Perspect 111(14):1744-1748
53. Tanaka-Kagawa T, Jinno H, Hasegawa T, Makino Y, Seko Y, Hanioka N, Ando M (2003) Functional characterization of two variant human GSTO 1-1 s (Ala140Asp and Thr217Asn). Biochem Biophys Res Commun 301:516-520
54. Thomas DJ (2007) Molecular processes in cellular arsenic metabolism. Toxicol Appl Pharmacol 222(3):365-373
55. Trouba KJ, Germolec DR (2004) Micromolar concentrations of sodium arsenite induce cyclooxygenase-2 expression and stimulate p42/44 mitogen-activated protein kinase phosphorylation in normal human epidermal keratinocytes. Toxicol Sci 79(2):248-257
56. Tseng CH (2008) Arsenic exposure and diabetes mellitus in the United States. JAMA 300(23):2728
57. Tseng CH (2009) A review on environmental factors regulating arsenic methylation in humans. Toxicol Appl Pharmacol 235(3):338-350
58. Tseng CH, Huang YK, Huang YL, Chung CJ, Yang MH, Chen CJ, Hsueh YM (2005) Arsenic exposure, urinary arsenic speciation, and peripheral vascular disease in blackfoot disease-hyperendemic villages in Taiwan. Toxicol Appl Pharmacol 206(3):299-308
59. Wang XJ, Sun Z, Chen W, Eblin KE, GandolW JA, Zhang DD (2007) Nrf2 protects human bladder urothelial cells from arsenite and monomethylarsonous acid toxicity. Toxicol Appl Pharmacol 225:206-213
60. Waugh DJ, Wilson C (2008) The interleukin-8 pathway in cancer. Clin Cancer Res 14(21):6735-6741
61. Wnek SM, Medeiros MK, Eblin KE, GandolW AJ (2009) Persistence of DNA damage following exposure of human bladder cells to chronic monomethylarsonous acid. Toxicol Appl Pharmacol 241(2):202-209
62. Wu J, Liu J, Waalkes MP, Cheng ML, Li L, Li CX, Yang Q (2008) High dietary fat exacerbates arsenic-induced liver Wbrosis in mice. Exp Biol Med (Maywood) 233(3):377-384
63. Xi S, Jin Y, Lv X, Sun G (2010) Distribution and speciation of arsenic by transplacental and early life exposure to inorganic arsenic in oVspring rats. Biol Trace Elem Res 134(1):84-97
64. Xie K (2001) Interleukin-8 and human cancer biology. Cytokine Growth Factor Rev 12(4):375-391
65. Yanbaeva DG, Wouters EF, Dentener MA, Spruit MA, Reynaert NL (2009) Association of glutathione-S-transferase omega haplotypes with susceptibility to chronic obstructive pulmonary disease. Free Radic Res 43(8):738-743
66. Yu L, Kalla K, Guthrie E, Vidrine A, Klimecki WT (2003) Genetic variation in genes associated with arsenic metabolism glutathione S transferase Omega 1-1 and purine nucleoside phosphorylase polymorphisms in European and indigenous Americans. Environ Health Perspect 111:1421-1427